EBC-129 demonstrates early activity and manageable safety in patients with heavily pretreated pancreatic cancer, supporting ...

Despite the advancement of AI and machine learning technologies and their incorporation into cancer treatment and drug development, a lack of trust and understanding of these new approaches is ...

The FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk ...

SFGATE columnist Drew Magary watched "Mountainhead," the latest movie coming from HBO Max, and found it perfect for the way ...

Johnson & Johnson (NYSE:JNJ) recently announced promising Phase 1 study results for Pasritamig, a novel antibody for advanced ...

The clinical trial tech companies Medidata and Medable are both taking to the floor of the American Society of Clinical ...

The Philadelphia Inquirer’s editorial board held nothing back in its condemnation of the Pennsylvania senator.

Shares of Tempus AI, Inc. (TEM) jumped 17% on Monday morning after the company announced a new liquid biopsy assay intended ...

Another impressive group of graduates is preparing to leave our beloved Laird Bell Quadrangle. Here, we highlight some of ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Northwestern Medical will begin using PathAI's AISight digital pathology image management system as part of the deal.

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending drug abiraterone, in clinical trial results presented by scientists from ...